Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma
- PMID: 35441778
- PMCID: PMC9519031
- DOI: 10.1002/ajmg.a.62761
Late-onset Proteus syndrome with cerebriform connective tissue nevus and subsequent development of intraductal papilloma
Abstract
Proteus syndrome (PS) is a rare segmental overgrowth disorder caused by a mosaic activating variant in AKT1. The features of PS are often not present at birth but develop during the first few years of life. We describe a 55-year-old female, whose first symptom of overgrowth, a cerebriform connective tissue nevus, occurred at 19 years of age. We report the identification of the AKT1 c.49G > A p.(Glu17Lys) variant in this progressive lesion, the bony overgrowth, and recurrence after surgical intervention. In the sixth decade of life, this individual developed intraductal papillomas within her right breast which were confirmed to contain the same activating AKT1 variant as the connective tissue nevus. While similar neoplasms have been described in an individual with Proteus syndrome, none has been evaluated for the presence of the AKT1 variant. The tumor also contained two likely pathogenic variants in PIK3R1, c.1392_1403dupTAGATTATATGA p.(Asp464_Tyr467dup) and c.1728_1730delGAG p.(Arg577del). The finding of additional genetic variation putatively affecting the PI3K/AKT pathway in the neoplastic tissue may provide preliminary evidence of a molecular mechanism for tumorigenesis in PS. The late onset of symptoms and molecular characterization of the breast tumor expand the clinical spectrum of this rare disorder.
Keywords: Proteus syndrome; connective tissue nevus; intraductal papilloma; overgrowth.
© 2022 Wiley Periodicals LLC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
Figures


Similar articles
-
Molecular heterogeneity of the cerebriform connective tissue nevus in mosaic overgrowth syndromes.Cold Spring Harb Mol Case Stud. 2019 Aug 1;5(4):a004036. doi: 10.1101/mcs.a004036. Print 2019 Aug. Cold Spring Harb Mol Case Stud. 2019. PMID: 31371346 Free PMC article.
-
A limited form of proteus syndrome with bilateral plantar cerebriform collagenomas and varicose veins secondary to a mosaic AKT1 mutation.JAMA Dermatol. 2014 Sep;150(9):990-3. doi: 10.1001/jamadermatol.2013.10368. JAMA Dermatol. 2014. PMID: 24850616 Free PMC article.
-
Proteus syndrome review: molecular, clinical, and pathologic features.Clin Genet. 2014 Feb;85(2):111-9. doi: 10.1111/cge.12266. Epub 2013 Oct 23. Clin Genet. 2014. PMID: 23992099 Review.
-
[A clinical study of Proteus syndrome caused by a mosaic somatic mutation in AKT1 gene].Zhonghua Nei Ke Za Zhi. 2019 Jul 1;58(7):508-513. doi: 10.3760/cma.j.issn.0578-1426.2019.07.005. Zhonghua Nei Ke Za Zhi. 2019. PMID: 31269567 Review. Chinese.
-
Dermatologic findings in individuals with genetically confirmed Proteus syndrome.Pediatr Dermatol. 2021 Jul;38(4):794-799. doi: 10.1111/pde.14624. Epub 2021 Jun 8. Pediatr Dermatol. 2021. PMID: 34105192 Free PMC article.
Cited by
-
Proteus Syndrome: Case Report and Updated Literature Review.Arch Plast Surg. 2024 Jun 14;51(4):423-431. doi: 10.1055/a-2300-7002. eCollection 2024 Jul. Arch Plast Surg. 2024. PMID: 39034978 Free PMC article.
References
-
- Cheung LW, Yu S, Zhang D, Li J, Ng PK, Panupinthu N, Mitra S, Ju Z, Yu Q, Liang H, Hawke DH, Lu Y, Broaddus RR, & Mills GB (2014). Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors. Cancer Cell, 26(4), 479–494. 10.1016/j.ccell.2014.08.017 - DOI - PMC - PubMed
-
- Çiloğlu S, Duran A, Önsal E, Yiğit K, & Onamay B (2015). Recurrence of isolated plantar cerebriform collagenoma. Turkish Journal of Dermatology, 9, 205–206. 10.4274/tdd.2246 - DOI
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous